Abortion


"KFF graphic with white text on a purple background that reads "Interactive Dashboard: Abortion in the United States." The graphic also has photo illustrations of the Supreme Court and abortion medication."

The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. It features a continuously-updated map tracking the status of abortion bans across the United States, as well as briefs on topics such as medication abortion, insurance coverage, ballot measures, legal developments, and racial and ethnic disparities. It also offers a jumping off point to the latest national and state-specific abortion policies and statistics. Visit the Dashboard →


Filter

61 - 70 of 283 Results

  • A Closer Look at Rape and Incest Exceptions in States with Abortion Bans and Early Gestational Restrictions

    Policy Watch

    Ten of the 21 states with abortion bans or gestational limits do not have an exception for pregnancies resulting from sexual assault. In the 11 states with rape and incest exceptions, the details and fine print make can make access to abortion care unattainable for pregnant survivors of sexual assault. Law enforcement reporting requirements, early pregnancy gestational limits, and the lack of provider availability present major barriers to abortion access, even when the state has an exception.

  • 2024 Women’s Health Survey

    Feature

    The 2024 KFF Women’s Health Survey (WHS) is the latest in a series of nationally representative surveys on women’s health conducted by KFF since 2001. The survey’s objective is to track and document women’s experiences and knowledge related to health and well-being.

  • Impact of the Mexico City Policy: Literature Review

    Issue Brief

    This literature review identifies studies examining the impact of the Mexico City Policy, from 2001 to the present, with particular focus on capturing recent studies assessing the policy under the Trump administration.

  • Supreme Court Cases on Content Moderation and Mifepristone Access — The Monitor

    Feature

    This issue of the Monitor focuses on recent Supreme Court decisions impacting health misinformation. We examine cases balancing free speech and platform regulation, the Court’s ruling on mifepristone access and public perceptions of social media moderation. We also explore COVID-19 narratives after Dr. Fauci’s congressional testimony and AI developments in predicting misinformation trends during pandemics.

  • Raw Milk Myths, Vaccine Falsehoods, and Reproductive Health Narratives – The Monitor

    Feature

    This first edition of the Health Misinformation Monitor explores misinformation about raw milk amid bird flu outbreaks on dairy farms, false vaccine narratives that continue to spread, and legal challenges against abortion pill reversal claims. Additionally, a growing number of states have required public schools to show fetal development videos that some have called biased and inaccurate. This Monitor report also provides a snapshot of new KFF misinformation polling on TikTok and discusses the early challenges faced by The World Health Organization’s new AI tool SARAH in providing accurate answers to health questions.

  • Emergency Abortion Care to Preserve the Health of Pregnant People: SCOTUS, EMTALA, and Beyond

    Policy Watch

    This policy watch outlines SCOTUS' June 27, 2024, decision dismissing the case, Moyle v. United States, where the Court had been asked to determine if a federal law called the Emergency Medical Treatment and Labor Act preempted Idaho's abortion ban. The decision returns the case to the lower courts and reinstates a court order blocking enforcement of the Idaho ban where it prohibits abortion care for pregnant people having medical emergencies.

  • Telemedicine in Sexual and Reproductive Health

    Issue Brief

    This brief presents an overview of telemedicine’s current use in sexual and reproductive health care, and reviews considerations in its coverage, potential to improve access, and financial implications for providers and patients.